Assisted Reproductive Technology and Pregnancy Outcome
Tracy Shevell(Stamford Hospital), Mary E. D’Alton(Rutgers, The State University of New Jersey), Ilan E. Timor‐Tritsch(Center for Discovery), Fergal D. Malone(Royal College of Surgeons in Ireland), Keith Eddleman(Columbia University), Sabrina Craigo(Tufts University), John Vidaver(Columbia University), Diana W. Bianchi(National Human Genome Research Institute), Siobhan M. Dolan(Albert Einstein College of Medicine), Lorraine Dugoff(University of Colorado Health), Honor M. Wolfe, Stephen R. Carr(Brown University), Gary D.V. Hankins(The University of Texas Medical Branch at Galveston), David A. Luthy(Citrix (Switzerland)), Christine H. Comstock(Beaumont Hospital, Royal Oak), T. Flint Porter(Intermountain Healthcare)
Cited by 354
Related Papers
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
|New England Journal of Medicine|2005|1.1k
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome
|Nature Genetics|2000|951
Impact of Maternal Age on Obstetric Outcome
|Obstetrics and Gynecology|2005|858
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)
|American Journal of Obstetrics and Gynecology|2004|620
Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery
|American Journal of Obstetrics and Gynecology|2008|620